Visualitzant Ciències de la Salut per autor/a "Hereu, Pilar"

Ara mostrant els elements 1-3 de 3

    • Daptomycin plus fosfomycin versus daptomycin alone for methicillin-resistant staphylococcus aureus bacteremia and endocarditis: a randomized clinical trial 

      Pujol, Miquel; Miró, José-María; Shaw, Evelyn; Aguado, Jose-María; San-Juan, Rafael; Puig-Asensio, Mireia; Pigrau, Carles; Calbo Sebastián, Esther; Montejo, Miguel; Rodriguez-Álvarez, Regino; Garcia-Pais, María-Jose; Pintado, Vicente; Escudero-Sánchez, Rosa; Lopez-Contreras, Joaquín; Morata, Laura; Montero, Milagros; Andrés, Marta; Pasquau, Juan; Arenas, María-del-Mar; Padilla, Belén; Murillas, Javier; Jover-Sáenz, Alfredo; López-Cortes, Luis-Eduardo; García-Pardo, Graciano; Gasch, Oriol; Videla, Sebastian; Hereu, Pilar; Tebé, Cristian; Pallarès, Natalia; Sanllorente, Mireia; Domínguez, María-Ángeles; Càmara, Jordi; Ferrer, Anna; Padullés, Ariadna; Cuervo, Guillermo; Carratalà, Jordi; MRSA Bacteremia (BACSARM) Trial Investigators (Clinical Infectious Diseases, 2020)
      Background: We aimed to determine whether daptomycin plus fosfomycin provides higher treatment success than daptomycin alone for methicillin-resistant Staphylococcus aureus (MRSA) bacteremia and ...

    • Methylprednisolone pulses plus tacrolimus in addition to standard of care vs. standard of care alone in patients with severe COVID-19. A randomized controlled trial 

      Solanich, Xavier; Antolí, Arnau; Rocamora-Blanch, Gemma; Padullés, Núria; Fanlo-Maresma, Marta; Iriarte, Adriana; Mitjavila, Francesca; Capdevila, Olga; Riera-Mestre, Antoni; Bas, Jordi; Vicens-Zygmunt, Vanesa; Niubó, Jordi; Calvo, Nahum; Bolivar, Santiago; Rigo-Bonnin, Raúl; Mensa-Vilaró, Anna; Arregui, Laura; Tebé, Cristian; Videla, Sebastià; Hereu, Pilar; Corbella Virós, Xavier (Frontiers in Medicine, 2021)
      Introduction: Severe lung injury is triggered by both the SARS-CoV-2 infection and the subsequent host-immune response in some COVID-19 patients. Methods: We conducted a randomized, single-center, ...

    • Pragmatic, open-label, single-center, randomized, phase II clinical trial to evaluate the efficacy and safety of methylprednisolone pulses and tacrolimus in patients with severe pneumonia secondary to COVID-19: the TACROVID trial protocol 

      Solanich, Xavier; Antolí, Arnau; Padullés, Núria; Fanlo-Maresma, Marta; Iriarte, Adriana; Mitjavila, Francesca; Capdevila, Olga; Molina, M.; Sabater-Riera, Joan; Bas, Jordi; Mensa-Vilaró, Anna; Niubó, Jordi; Calvo, Nahum; Bolivar, Santiago; Rigo-Bonnin, Raúl; Arregui, Laura; Tebé, Cristian; Hereu, Pilar; Videla, S.; Corbella Virós, Xavier (Contemporary Clinical Trials Communications, 2021-03)
      Introduction: Some COVID-19 patients evolve to severe lung injury and systemic hyperinflammatory syndrome triggered by both the coronavirus infection and the subsequent host-immune response. Accordingly, ...